Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.

STERIS LIMITED

OPERATIONAL NOTE – NOT FOR PUBLICATION

27 June 2005

NATIONWIDE AMBULANCE RESEARCH WILL REVEAL UNIVERSAL INFECTION RISK TO STAFF AND PATIENTS

Nationwide MRSA related infection research in ambulances will be unveiled at the NHS Ambulance Services Association’s annual conference (AMBEX) at Harrogate on 1 July 2005.

This research will provide figures for the first time on the degree of harmful infection present in the NHS ambulance fleet and the potential for onward transmission into hospitals.

Half of the NHS ambulance trusts in England, Wales, Scotland and Northern Ireland participated in the research trials to find out more about the levels of contamination in NHS ambulances and what can be done to address the problem.

The new research findings will be revealed at a press briefing event on Friday 1 July in the Press Room at the front of Hall A at the Harrogate International Conference Centre, between 11 am and 12 noon. Full details of the AMBEX event are available from the link below, including pre-registration.

Speakers at the briefing will include Cliff Randall from the Welsh Ambulance Services NHS Trust, Peter Howard-Jones from UV Modular (an ambulance manufacturer from West Yorkshire), Philip Ward, Managing Director of Ferno (UK) Limited (an ambulance equipment manufacturer), and Dr Gerald McDonnell from STERIS Limited of Basingstoke (a global provider of innovative infection prevention, decontamination and health science technologies, products and services.

ENDS

Notes to Editors:

1. Further media inquiries only to Nick Sutcliffe (+44 7730 898 165) or Jonathan Simpson (+44 7968 537 320).

2. Pre-registration for AMBEX is available at www.ambex.net

This press release was distributed by ResponseSource Press Release Wire on behalf of APCO UK in the following categories: Health, Medical & Pharmaceutical, for more information visit https://pressreleasewire.responsesource.com/about.